We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Final Rule Expands Criteria for Reporting Drug Stoppages
Final Rule Expands Criteria for Reporting Drug Stoppages
December 16, 2011
The FDA has issued an interim final rule requiring drugmakers to report interruptions in the production of critical drugs.